Drug Utilization Review

The Idaho Drug Utilization Review (DUR) Program was established in 1993 to fulfill specific requirements of the Omnibus Budget Reconciliation Act of 1990 (OBRA 90) as a contingency for the Idaho Department of Health and Welfare to receive federal funding. The DUR program uses a structured process to review claims data and interpret patterns of drug use in relation to predetermined criteria. The goals of the program are to reduce potentially inappropriate prescribing and dispensing of medications, enhance the counseling of patients, and reduce growth in expenditures for drugs.

Board members

  • Christopher Partridge, MD (Meridian, serving since 2020)
  • Dawn Berheim, PharmD (Meridian, serving since 2020)
  • Magni Hamso, MD (Boise, serving since 2020)
  • Perry Brown, MD (Physician, Boise)
  • Sabrina Allen, PharmD (Boise, serving since 2020)
  • Tami Eide, PharmD (Boise, serving since 2002)
  • Walter L Fitzgerald, Jr., BPharm, MS, JD, Dean (Pocatello, serving since 2021)
  • Wayne Baures, RPh (Spirit Lake, serving since 2012)

2021 Meeting Dates

January 21, 2021 - CANCELLED
April 15, 2021 - Call-in Information
July 15, 2021
October 21, 2021

Minutes & Agendas

Contacts
Mark England, PharmD
Magellan Medicaid Administration
Phone
(208) 473-2272
Email
MLEngland@magellanhealth.com